A dry-phase fluorescent immunoassay detection platform for in vitro diagnostic testing. The analyzer provides rapid results with high sensitivity and is designed for point-of-care applications across multiple clinical disciplines.
Manufactured by
China
Xenta Biomedical Science Co., Ltd, founded in December 2021 and headquartered in Guangzhou Development District, is a national high-tech enterprise focused on the R&D, registration, and commercialization of in vitro diagnostic (IVD) reagents and devices. With fully paid-up capital of RMB 10 million, the company is led by a team of returnee PhDs with strong international research and industry experience. It is dedicated to developing innovative POCT technology platforms under the philosophy of "Faster, Better, and More Accessible". The company drives innovation through R&D centers in Guangzhou, Xiamen, and overseas. Using its proprietary dry light-excited chemiluminescence POCT platform, it has developed leading product series and managed major national research projects. The company has published over 20 SCI papers, holds 70 patents, has obtained more than 60 EU CE certifications, and 12 FDA approvals in the United States. Currently, several product lines are actively striving for NMPA certification. Its pipeline covers key areas including cardiovascular, inflammation, oncology, hormone, and infectious diseases, demonstrating end-to-end capabilities from R&D to global commercialization. The core team comprises graduates from top universities such as Texas A&M University, Xiamen University, Sanford-Burnham Medical Research Institute, and Sun Yat-sen University, possessing multidisciplinary expertise in biomedicine, engineering, and law. The co-founders have extensive experience from leading IVD companies, having previously guided teams to achieve annual revenues exceeding several hundred million yuan and secure over 200 product certifications worldwide. Since its establishment, Xenta Biomedical Science Co., Ltd has raised tens of millions in funding and obtained ISO 13485 certification, supporting its global expansion.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shenzhen Diasia Biomedical Technology Co.,Ltd
China · 1 relevant product
SJK Global LLC
United States · 1 relevant product
Beijing O&D Biotech Co., Ltd.
China · 1 relevant product
Shanghai i-Reader biotech Co.,Ltd
China · 2 relevant products
Xiamen Boson Biotech Co., Ltd
China · 2 relevant products
Beijing Sinomedisite Bio-tech Co., Ltd
China · 1 relevant product
Shenzhen Microprofit Biotech Co., Ltd
China · 1 relevant product
Athenese-Dx Private Limited
India · 1 relevant product
Guangzhou Wondfo Biotech Co., Ltd.
China · 1 relevant product
Chongqing Isia Bio-Technology Co Ltd
China · 2 relevant products
11 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 26 closest product alternatives
Shenzhen Diasia Biomedical Technology Co.,Ltd · China
A high-precision analyzer utilizing fluorescence immunoassay (FIA) technology for rapid immunological testing and diagnosis. The system is designed for clinical chemistry and immunofluorescence applications in point-of-care testing.
SJK Global LLC · United States
Fluorescence-based immunoassay technology for point-of-care applications using the LTRIC-600 benchtop analyzer. FIA provides rapid results with sensitive detection capabilities.
Beijing O&D Biotech Co., Ltd. · China
A dry fluorescence immunoassay analyzer designed for clinical diagnostic testing. This device is registered under the medical device approval number Xiang械注准20202220773. It is intended for use in laboratory settings to perform fluorescence-based immunoassays on patient samples.
Shanghai i-Reader biotech Co.,Ltd · China
A fluorescence immunochromatographic analyzer instrument for in vitro diagnostic testing. The device utilizes fluorescence-based detection for rapid immunoassay analysis.
Xiamen Boson Biotech Co., Ltd · China
A single-channel fluorescence immunoassay system designed for ease of use with a 3.5-inch screen and intuitive user interface. The analyzer is compact and suitable for point-of-care diagnostic applications.
Beijing Sinomedisite Bio-tech Co., Ltd · China
Fluorescence immunochromatography analyzer for rapid point-of-care testing (POCT) and clinical diagnostics. Detects biomarkers and analytes using fluorescence-based immunoassay technology for disease screening and monitoring. Integrates with chronic disease management systems for automated result processing and data management.
Shenzhen Microprofit Biotech Co., Ltd · China
CE-marked fluorescence immunoassay (FIA) analyzer for quantitative point-of-care testing. The MF-T1000 platform delivers rapid diagnostic results with 92.9%+ sensitivity, supporting respiratory combo tests (4-in-1/9-in-1 configurations) for clinical laboratories and healthcare facilities.
Athenese-Dx Private Limited · India
Fluorescence Immunoassay is an in vitro diagnostic test kit for clinical laboratory use, employing fluorescent detection technology to quantify analytes in patient samples. This method enables rapid, sensitive measurement of biomarkers across clinical chemistry and immunology applications with high specificity and reproducibility.
Guangzhou Wondfo Biotech Co., Ltd. · China
Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.
Chongqing Isia Bio-Technology Co Ltd · China
A single-channel fluorescent immunoassay analyzer based on quantum dots immunofluorescence technology. It is designed for point-of-care testing (POCT) applications with enhanced signal-to-noise ratio and reliable performance for in vitro diagnostics.
SHENZHENSHI HIGHCREATION TECHNOLOGY CO.,LTD · China
A dry-format fluorescence immunoassay analyzer for clinical laboratory diagnostics. The instrument performs fluorescence-based immunoassay testing without requiring liquid reagents, offering convenience for routine immunological testing.
Beijing Zhongjian Antai Diagnostic Co., Ltd. · China
Fluorescence quantitative immunoassay platform for in vitro diagnostic testing of infectious diseases, respiratory pathogens, and gastrointestinal markers. The system enables quantitative analysis using fluorescence immunoassay technology with Class II medical device certification across multiple regulatory markets. Supports high-throughput diagnostic workflows in clinical laboratories and reference testing facilities.
14 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products